Sickle Cell Disease Comprehensive Care Act This bill allows state Medicaid programs to establish health homes to provide coordinated care for individuals with sickle-cell disease. (Under current law, state Medicaid programs may establish health homes to provide coordinated care for individuals with specified chronic conditions.) States must ensure that such care includes dental and vision services. The Centers for Medicare & Medicaid Services must issue best practices for states on how to design and implement such health homes.
Read twice and referred to the Committee on Finance.
Bill introduced
Lobbying filed by NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION
Lobbying filed by AMERICAN SOCIETY OF HEMATOLOGY
Lobbying filed by NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION
Lobbying filed by AMERICAN SOCIETY OF HEMATOLOGY
Read twice and referred to the Committee on Finance.
| Registrant | Client | Amount | Filed | Period | Issues |
|---|---|---|---|---|---|
| THE NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION | NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION | $349.4K | Jul 18, 2025 | 2025Q2 | BUDHCRMMM |
| THE NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION | NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION | $247.5K | Apr 18, 2025 | 2025Q1 | AGRBUDHCR |
The lobbying table lists Senate LDA quarterly reports (LD-2) that cite this bill by number and cover a quarter of the 119th Congress. An LD-2 names a bill as “H.R. 1234” with no Congress, so a report on another Congress, which can only concern a different bill with the same number, is left out, even when it was filed after this Congress began. The amount is what the registrant reported for the whole filing, across every issue on it, not spending on this bill. Official actions and the bill summary come from Congress.gov, and votes from the roll-call record. This page no longer pairs the bill with members' stock trades: matching lobbying clients to traded companies by name, and trades to a bill by date, is not something the records establish.
Lobbying filed by AMERICAN SOCIETY OF HEMATOLOGY
| CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | AMERICAN SOCIETY OF HEMATOLOGY | $40.0K | Jul 18, 2025 | 2025Q2 | HCRMMM |
| CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | AMERICAN SOCIETY OF HEMATOLOGY | $40.0K | Apr 18, 2025 | 2025Q1 | HCR |
| AMERICAN SOCIETY OF HEMATOLOGY | AMERICAN SOCIETY OF HEMATOLOGY | $30.0K | Jul 21, 2025 | 2025Q2 | HCRBUDMED |
| INDIGO HILL STRATEGIES | SICK CELLS | $30.0K | Jul 15, 2025 | 2025Q2 | BUDHCR |
| AMERICAN SOCIETY OF HEMATOLOGY | AMERICAN SOCIETY OF HEMATOLOGY | $30.0K | Apr 9, 2025 | 2025Q1 | BUDMEDMMM |
| TERUMO BCT, INC. | TERUMO BCT, INC. | $20.0K | Jul 22, 2025 | 2025Q2 | TRDHCR |
| ARTEMIS POLICY GROUP LLC | SICKLE CELL DISEASE ASSOCIATION OF AMERICA | $20.0K | Jul 18, 2025 | 2025Q2 | HCRMMMBUD |
| ARTEMIS POLICY GROUP LLC | SICKLE CELL DISEASE ASSOCIATION OF AMERICA | $20.0K | Apr 21, 2025 | 2025Q1 | HCRMMMBUD |
| TERUMO BCT, INC. | TERUMO BCT, INC. | $20.0K | Apr 16, 2025 | 2025Q1 | TRDHCR |